273 results on '"Nagel, Inga"'
Search Results
2. STIGMA: Single-cell tissue-specific gene prioritization using machine learning
3. CRISPR/Cas9-induced knockout reveals the role of ABCB1 in the response to temozolomide, carmustine and lomustine in glioblastoma multiforme
4. UBTF::ATXN7L3 gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment
5. Position effects at the FGF8 locus are associated with femoral hypoplasia
6. Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features
7. CTCF variants in 39 individuals with a variable neurodevelopmental disorder broaden the mutational and clinical spectrum
8. Annular pancreas in two sisters: The story goes on
9. Double-hit lymphoma of the male breast: a case report
10. Molecular Analysis of Hybrid Neurofibroma/Schwannoma Identifies Common Monosomy 22 and α-T-Catenin/CTNNA3 as a Novel Candidate Tumor Suppressor
11. MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study
12. Identifying molecular markers for the sensitive detection of residual atypical teratoid rhabdoid tumor cells
13. A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma
14. Rewiring of liver diurnal transcriptome rhythms by triiodothyronine (T3) supplementation
15. Author response: Rewiring of liver diurnal transcriptome rhythms by triiodothyronine (T3) supplementation
16. Kinderhandel in Westafrika
17. The genomic and transcriptional landscape of primary central nervous system lymphoma
18. MYC expression and translocation analyses in low‐grade and transformed follicular lymphoma
19. Clonal evolution in tyrosine kinase inhibitor-resistance: lessons from in vitro-models.
20. Genome‑wide expression and methylation analyses reveal aberrant cell adhesion signaling in tyrosine kinase inhibitor‑resistant CML cells
21. Rewiring of liver diurnal transcriptome rhythms by triiodothyronine (T3) supplementation
22. SMARCA4-mutated atypical teratoid/rhabdoid tumors are associated with inherited germline alterations and poor prognosis
23. Genes encoding members of the JAK-STAT pathway or epigenetic regulators are recurrently mutated in T-cell prolymphocytic leukaemia
24. Immunoglobulin heavy chain locus chromosomal translocations in B-cell precursor acute lymphoblastic leukemia: rare clinical curios or potent genetic drivers?
25. The landscape of genomic alterations across childhood cancers
26. ALK-positive primary cutaneous T-cell-lymphoma (CTCL) with unusual clinical presentation and aggressive course
27. Clinical and pathological features of Burkitt lymphoma showing expression of BCL2 – an analysis including gene expression in formalin-fixed paraffin-embedded tissue
28. Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations
29. Detection of SMARCB1 loss in ascites cells in the diagnosis of an abdominal rhabdoid tumor
30. ZFP36L1 plays an ambiguous role in the regulation of cell expansion and negatively regulates CDKN1A in chronic myeloid leukemia cells
31. Position effects at the FGF8 locus are associated with femoral hypoplasia
32. Peritoneal dissemination of a gastric API2-MALT1-positive MALT lymphoma
33. A familial disorder of altered DNA-methylation
34. Bilateral ganglioglioma of the trigeminal nerve in an 83-year-old man
35. Partially Levodopa‐Responsive Parkinsonism in a Carrier of a Novel Pathogenic CLTC Variant.
36. Molecular characterization of Burkitt lymphoma in the breast or ovary
37. Rewiring of liver diurnal transcriptome rhythms by triiodothyronine (T3) supplementation.
38. The landscape of genomic alterations across childhood cancers
39. Frequent triple-hit expression of MYC, BCL2, and BCL6 in primary lymphoma of the central nervous system and absence of a favorable MYClowBCL2low subgroup may underlie the inferior prognosis as compared to systemic diffuse large B cell lymphomas
40. Microdeletion 5q14.3 and anomalies of brain development
41. X-Linked Dystonia-Parkinsonism Manifesting in a Female Patient Due to Atypical Turner Syndrome
42. BTK acts as a modulator of the response to imatinib in chronic myeloid leukemia.
43. Recurrent deletions of the TNFSF7 and TNFSF9 genes in 19p13.3 in diffuse large B-cell and Burkitt lymphomas
44. The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma
45. Annular pancreas in two sisters: The story goes on.
46. IG-MYC+ neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas
47. UBTF::ATXN7L3gene fusion defines novel B cell precursor ALL subtype with CDX2 expression and need for intensified treatment
48. IG‐MYC ‐positive leukemia and lymphoma with precursor B‐cell phenotype are genetically and epigenetically distinct from Burkitt lymphomas
49. The landscape of genomic alterations across childhood cancers
50. Alternative Polyadenylation of ABC Transporters of the C-Family (ABCC1, ABCC2, ABCC3) and Implications on Posttranscriptional Micro-RNA Regulation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.